| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/14/2004 | CN1145626C Substituted pyrazole-3-yl benzazoles compound and use in agriculture |
| 04/14/2004 | CN1145623C Imidazole derivatives |
| 04/14/2004 | CN1145618C Cycloformate derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145610C Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 04/13/2004 | US6720343 (((4-(3-thien-2-yl-1,2,4-oxadiazol-5-yl)phenyl)sulfonyl) amino)acetic acid, optionally substituted; selective matrix metalloprotease (mmp-2) inhibition; low protein binding, high blood concentration, no p-450 inhibition |
| 04/13/2004 | US6720336 4,4-biarylpiperidine derivatives |
| 04/13/2004 | US6720335 Sulfonamide inhibitors of aspartyl protease |
| 04/13/2004 | US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) |
| 04/13/2004 | US6720324 Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
| 04/13/2004 | US6720320 Phenoxypropylamine compounds |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/08/2004 | WO2004029066A2 Bifunctional heterocyclic compounds and methods of making and using same |
| 04/08/2004 | WO2004029048A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/08/2004 | WO2004029040A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
| 04/08/2004 | WO2004029027A1 Pyridine derivatives as cb2 receptor modulators |
| 04/08/2004 | WO2004028540A1 Anti-neurodegenerative agents |
| 04/08/2004 | WO2004028530A1 N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| 04/08/2004 | WO2004017961A3 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/08/2004 | WO2004016604A3 Azabicyclic compounds are central nervous system active agents |
| 04/08/2004 | WO2004010761A3 Pesticidal cyanine dye derivatives |
| 04/08/2004 | WO2003106452A3 Antagonists of melanin concentrating hormone receptor |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003057225A3 Phosphate transport inhibitors |
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | WO2003018553A8 Oral antidiabetic agents |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068012 Anticancer agents; protease enzyme inhibitor |
| 04/08/2004 | US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 04/08/2004 | US20040067997 Respiratory syncytial virus |
| 04/08/2004 | US20040067994 Grampositive, gramnegative bacteria therapy |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | US20040067976 Compounds useful for treating Hepatitis C virus |
| 04/08/2004 | US20040067968 Antitumor, anticancer agents |
| 04/08/2004 | US20040067964 Antiinflammatory agents |
| 04/08/2004 | US20040067961 Organ grafting; antiarthritic agents; inflammatory bowel disease |
| 04/08/2004 | US20040067960 Central nervous system disorders; Alzheimers's, Parkinson's, Huntington disease |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040067941 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067935 N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| 04/08/2004 | US20040067931 Benzimidazolidinone derivatives as muscarinic agents |
| 04/08/2004 | US20040067914 R-NSAID esters and their use |
| 04/08/2004 | US20040067387 Organic compounds for electroluminescence and organic electroluminescent devices using the same |
| 04/08/2004 | CA2500420A1 Anti-neurodegenerative agents |
| 04/08/2004 | CA2500221A1 Substituted 3-(2,5 -disubstituted) pyridyl-4-aryl pyrroles for treating inflammatory diseases |
| 04/08/2004 | CA2500158A1 Bifunctional heterocyclic compounds and methods of making and using same |
| 04/08/2004 | CA2500115A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/07/2004 | EP1405853A1 Isoxazoline derivatives and herbicides |
| 04/07/2004 | EP1405848A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 04/07/2004 | EP1404681A1 Process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives |
| 04/07/2004 | EP1404671A1 Macrocycles useful in the treatment of alzheimer's disease |
| 04/07/2004 | EP1404339A2 Method for treating fibrotic diseases or other indications vi |
| 04/07/2004 | EP1404335A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1149087B1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 04/07/2004 | EP0934289B1 Oxime derivatives and their use as fungicides |
| 04/07/2004 | CN1487936A Medicinal compositions having improved absorbability |
| 04/07/2004 | CN1487935A Medicinal compositions improved in solubility in water |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487920A Deltal-pyrrolines used as pesticides |
| 04/07/2004 | CN1487919A New mandelic acid derivatives and their use as throbin inhibitors |
| 04/07/2004 | CN1144794C Benzoxazine and benzothiazine derivatives and their application in medicines |
| 04/07/2004 | CN1144791C Triazole compounds and its application as dopamine-D3-ligands |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2004 | US6716998 Such as (2r)-3,4-dihydro-2h-chromen-2-yl-methyl-4-methyl-benzenesulfonate; metathesis ring closing polymerization |
| 04/06/2004 | US6716987 Phosphodiesterase iv inhibitors |
| 04/06/2004 | US6716980 Cyclization and acylation of carbamate |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716866 Aryl-benzimidazole compounds having antiinfective activity |
| 04/06/2004 | US6716865 Benzoxa- and benzthiazoles |
| 04/06/2004 | US6716863 Heterocyclic compounds their production and use |
| 04/06/2004 | US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent |
| 04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716847 Antiallergens, antiinflammatory |
| 04/06/2004 | US6716842 Non-insulin dependent diabetes mellitus, obesity, hyperglycemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia in a mammal |
| 04/06/2004 | US6716841 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 04/06/2004 | US6716834 Thiochromane derivatives and their use as thrombin inhibitors |
| 04/06/2004 | US6716605 Indole derivatives having an antiviral activity |
| 04/06/2004 | CA2124306C Quinazolinone derivatives |
| 04/06/2004 | CA2067381C Treatment of hiv infections and compounds useful therein |
| 04/01/2004 | WO2004027378A2 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 04/01/2004 | WO2004026865A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026864A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | WO2004026863A1 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026859A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026848A1 Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents |
| 04/01/2004 | WO2004026844A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | WO2004026843A1 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 04/01/2004 | WO2004026829A2 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibitors |
| 04/01/2004 | WO2004026794A2 Removal of aldehyde impurity by reactive polystyrene resin |
| 04/01/2004 | WO2004026307A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026306A2 Pyrazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026305A1 Diaryl ethers as opioid receptor antagonist |
| 04/01/2004 | WO2004026292A1 Antitussives |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2002098852A8 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/01/2004 | WO2002085897A9 Heterocyclic compounds for aging-related and diabetic vascular complications |